Funding news
Oryon Cell Therapies logo

Oryon Cell Therapies Raises $2

Recently funded · $21.0M Series aHospitals and Health CareUSView source

Get the full Oryon Cell Therapies company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The quest to restore synaptic function and motor control for patients with neurodegenerative disorders just got a significant boost. Oryon Cell Therapies, a clinical-stage biotechnology company, has closed a $21.0M Series A funding round.

The capital, backed by investors Neuro.VC and Byers Capital, will advance Oryon’s work on autologous cell therapies, initially targeting Parkinson’s disease. Co-founded in 2020 by Ole Isacson, M.D. Ph.D., and Nikola Kojic, M.D., Ph.D., the company’s technology is designed to replace lost neurons with the goal of achieving functional restoration.

From the source

Omkar · Mar 23, 2026

🧠🔬 Advancing Parkinson’s Disease Care Through Education and Regenerative Medicine The fight against Parkinson’s disease (PD) continues to gain momentum, with two notable developments highlighting progress in both clinical education and next-generation therapeutic innovation.

📚 ISSCR Launches New Parkinson’s Disease Education Course In March 2026, the International Society for Stem Cell Research (ISSCR) introduced Stem Cell Medicine: Parkinson’s Disease, a continuing education program designed to provide clinicians with an evidence-based understanding of emerging stem cell therapies for PD. As regenerative medicine rapidly evolves, this initiative aims to help health

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Maneva logo

Maneva

Canada

$27.0M
2
Infinity Constellation logo

Infinity Constellation

$24.0M
3
Fesarius Therapeutics logo

Fesarius Therapeutics

United States

$20.0M
4
Pi logo

Pi

Turkey

$35.0M
5
Social Hardware logo

Social Hardware

India

$1.1M